Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Journal of Nuclear Medicine Supplement summarizes current molecular radiotherapy

21.01.2005


Supplement projects future possibilities and partnering with patients in providing care



A special supplement to the Society of Nuclear Medicine’s Journal of Nuclear Medicine examines current and future uses of radionuclide therapy and its importance in medical practice and patient management.

Supplement editors Steven M. Larson, M.D., and Eric P. Krenning, M.D., Ph.D., present a comprehensive overview intended to offer relevant advice to nuclear medicine practitioners and other professionals who may be actively involved in radionuclide therapy and to provide them with a summary of suggested patterns of practice for common radionuclide therapies now available. They also include a forecast of the near-term opportunities that are likely to determine practice in the next few years.


Radionuclide therapy is an important and increasingly significant component of modern medical practice for a growing number of patients with thyroid cancer, lymphoma, metastatic bone involvement with prostate and breast cancer and carcinoid tumors, explained Larson, who is chief of nuclear medicine at Memorial Sloan-Kettering Cancer Center, New York, N.Y. Larson and Eric P. Krenning, M.D., Ph.D., Erasmus University Medical Center, Rotterdam, the Netherlands, are guest editors for the 204-page volume of "Clinical Practice of Molecular Radiotherapy," released in January.

In their introduction, Larson and Krenning note, "More and more, interested patients and their families will become partners in care in radionuclide therapy." To illustrate this and other points, the editors chose a dramatic photo for the cover symbolizing an important segment of the treatment population--women with thyroid cancer--one that has the distinction of being the most rapidly increasing in incidence in this country. "Nuclear medicine will play a growing role in the care of thyroid cancer and other tumors in the future," Larson said. Larson and Krenning also draw attention to the importance of cancer survivor groups in setting policy and promoting cancer awareness.

This essential resource includes the introduction, "A Pragmatic Perspective on Molecular Targeted Radionuclide Therapy," along with 26 articles (including black and white and color images) addressing future applications, conventional therapies, tumor-seeking peptides in therapy and tumor-seeking monoclonal antibodies. Articles include "Radiobiologic Principles in Radionuclide Therapy"; "The Evolving Role of 131I for the Treatment of Differentiated Thyroid Carcinoma"; "Bone-Seeking Radionuclides for Therapy"; "Radiosynovectomy in Rheumatology, Orthopedics and Hemophilia"; "Candidates for Peptide Receptor Radiotherapy Today and in the Future"; "Perspectives on Cancer Therapy With Radiolabeled Monoclonal Antibodies"; "The Promise of Immuno-PET in Radioimmunotherapy"; "Radiotargeted Gene Therapy"; and "Radiation Sensitizers: A Selective Review of Molecules Targeting DNA and non-DNA Targets."

"This supplement offers significant information for nuclear/molecular imaging professionals and deserves a place in your professional library," notes Heinrich R. Schelbert, M.D., Ph.D., editor of the Journal of Nuclear Medicine. JNM is the most prominent peer-reviewed journal in nuclear medicine, molecular imaging and allied disciplines. Not only does JNM rank among the top imaging journals, its impact factor puts it in the top 5 percent of all scientific serials rated by the Institute for Scientific Information. Published monthly, JNM features clinical investigations and basic science papers, continuing education articles, book reviews, an event calendar and an employment section.

Maryann Verrillo | EurekAlert!
Further information:
http://www.snm.org
http://jnm.snmjournals.org

More articles from Health and Medicine:

nachricht 'Living bandages': NUST MISIS scientists develop biocompatible anti-burn nanofibers
16.02.2018 | National University of Science and Technology MISIS

nachricht New process allows tailor-made malaria research
16.02.2018 | Eberhard Karls Universität Tübingen

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: In best circles: First integrated circuit from self-assembled polymer

For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.

In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

Im Focus: Hybrid optics bring color imaging using ultrathin metalenses into focus

For photographers and scientists, lenses are lifesavers. They reflect and refract light, making possible the imaging systems that drive discovery through the microscope and preserve history through cameras.

But today's glass-based lenses are bulky and resist miniaturization. Next-generation technologies, such as ultrathin cameras or tiny microscopes, require...

Im Focus: Stem cell divisions in the adult brain seen for the first time

Scientists from the University of Zurich have succeeded for the first time in tracking individual stem cells and their neuronal progeny over months within the intact adult brain. This study sheds light on how new neurons are produced throughout life.

The generation of new nerve cells was once thought to taper off at the end of embryonic development. However, recent research has shown that the adult brain...

Im Focus: Interference as a new method for cooling quantum devices

Theoretical physicists propose to use negative interference to control heat flow in quantum devices. Study published in Physical Review Letters

Quantum computer parts are sensitive and need to be cooled to very low temperatures. Their tiny size makes them particularly susceptible to a temperature...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on High Temperature Shape Memory Alloys (HTSMAs)

15.02.2018 | Event News

Aachen DC Grid Summit 2018

13.02.2018 | Event News

How Global Climate Policy Can Learn from the Energy Transition

12.02.2018 | Event News

 
Latest News

'Lipid asymmetry' plays key role in activating immune cells

20.02.2018 | Life Sciences

MRI technique differentiates benign breast lesions from malignancies

20.02.2018 | Medical Engineering

Major discovery in controlling quantum states of single atoms

20.02.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>